3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Lymphoma
19
Lymphoma, Large B-Cell, Diffuse
17
Hodgkin Disease
8
Lymphoma, Non-Hodgkin
7
Lymphoma, Follicular
5
Leukemia
5
Hemangioma
5
Lymphoma, Large-Cell, Anaplastic
4
Prostatic Neoplasms
3
Neoplasms
3
Lymphoma, B-Cell
3
Immunoblastic Lymphadenopathy
3
Neurotoxicity Syndromes
2
Neoplasm, Residual
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Esophageal Stenosis
2
Enteropathy-Associated T-Cell Lymphoma
2
Vomiting
1
Thymoma
1
Recurrence
1
Pulmonary Disease, Chronic Obstructive
1
Polycystic Ovary Syndrome
1
Philadelphia Chromosome
1
Neoplasm Metastasis
1
Neoadjuvant Therapy
1
Nausea
1
Interventions
Cyclophosphamide
41
Peripheral Blood Stem Cell Transplantation
40
fludarabine phosphate
36
Whole-Body Irradiation
27
Mycophenolic Acid
27
Tacrolimus
23
Busulfan
23
Cyclosporine
22
Antilymphocyte Serum
20
Etoposide
17
Methotrexate
16
Filgrastim
16
Melphalan
14
romidepsin
13
Radiotherapy
13
Flow Cytometry
12
Methylprednisolone
10
Brentuximab Vedotin
10
Therapeutics
9
Psychiatric Rehabilitation
9
Lenalidomide
8
pembrolizumab
7
fludarabine
7
Sirolimus
7
Rituximab
7
Bortezomib
7
Bexarotene
7
mogamulizumab
6
Polymerase Chain Reaction
6
Gemcitabine
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoma, T-Cell, Cutaneous
×
Prednisolone
×
Clear all
NCT01198665
2015-03-03
RADCHOP
Samsung Medical Center
Phase 1/2
Completed
46 enrolled